Clinical Trials

120 enrolled

Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT07476287 2026-03-17

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

40 enrolled

Lung Neoplasms, Small Cell Lung Carcinoma

NCT07001995 2026-03-16

Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07472517 2026-03-16

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

670 enrolled

Small Cell Lung Carcinoma

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07391670 2026-03-12

IMFINZI-subQ

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Small Cell Lung Carcinoma

NCT07465757 2026-03-12

ALISCA-Lung2

50 enrolled

Small Cell Lung Carcinoma

NCT07468656 2026-03-12

SCLC Tarlatamab Blood Collection

25 enrolled

Small Cell Lung Carcinoma

NCT07459634 2026-03-10

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

50 enrolled

Small Cell Lung Carcinoma

NCT07231445 2026-03-04

Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer

100 enrolled

Small Cell Lung Carcinoma

NCT07402343 2026-03-04

T-BRAIN

34 enrolled

CNSThoracic

Brain Neoplasms, Small Cell Lung Carcinoma

NCT07414927 2026-02-17

A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy

48 enrolled

Small Cell Lung Carcinoma

NCT07407933 2026-02-12

A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors

118 enrolled

Lung Diseases, Thoracic Neoplasms, Small Cell Lung Carcinoma

NCT07398560 2026-02-10

Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

47 enrolled

Small Cell Lung Carcinoma

NCT07388875 2026-02-05

SKB264-ANLO

Phase NA Not yet recruiting

Small Cell Lung Carcinoma

NCT07383454 2026-02-03

Lung Cancer Screening in Population Who Had Never Smoked

2,500 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07376499 2026-01-29

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

31 enrolled

Small Cell Lung Carcinoma

NCT07365241 2026-01-26

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

531 enrolled

Neoplasms, Small Cell Lung Carcinoma

NCT07357532 2026-01-22

Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD

44 enrolled

Small Cell Lung Carcinoma

NCT07358676 2026-01-22

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

25 enrolled

Small Cell Lung Carcinoma

NCT07296809 2025-12-30

SKB500 Combinations in Patients With Small Cell Lung Cancer

80 enrolled

Small Cell Lung Carcinoma

NCT07153055 2025-12-18

LOTS

16 enrolled

Small Cell Lung Carcinoma

NCT07253142 2025-12-02

A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer

120 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07249879 2025-11-25

This Study is an Open-lable, Phase I Study to Evaluate the Safety, Feasibility, Cytokinetics, and Preliminary Efficacy of GC511B in DLL3+ Relapsed/Refractory Small Cell Lung Cancer.

55 enrolled

Small Cell Lung Carcinoma

NCT07206563 2025-10-03

Penfluridol for Relapsed/Refractory Small Cell Cancers

33 enrolled

Recurrence, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT07200154 2025-09-30

Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Small Cell Lung Carcinoma

NCT07177937 2025-09-22

A Study of DXC014 in Patients With Advanced Solid Tumors.

DermatologicGenitourinaryThoracic

150 enrolled

Melanoma, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT07173244 2025-09-15

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

300 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Small Cell Lung Carcinoma

NCT07173946 2025-09-15

Prospective Observational Study on ES-SCLC

96 enrolled

Small Cell Lung Carcinoma

NCT07110363 2025-08-07

A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

58 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07103408 2025-08-05

A Study Evaluating Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade for Limited-stage Small Cell Lung Cancer

56 enrolled

Small Cell Lung Carcinoma

NCT07075627 2025-08-01

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

400 enrolled

Lambert-Eaton Myasthenic Syndrome, Small Cell Lung Carcinoma

NCT07097948 2025-08-01

Adjuvant

40 enrolled

Phase NA Not yet recruiting

Recurrence, Small Cell Lung Carcinoma

NCT07076836 2025-07-22

Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

82 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07076914 2025-07-22

PPI-PROTECT

58 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07076095 2025-07-21

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

200 enrolled

Small Cell Lung Carcinoma

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

28 enrolled

Small Cell Lung Carcinoma

NCT07055581 2025-07-09

Durvalumab as Consolidation for Patients LS-SCLC

100 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Small Cell Lung Carcinoma

NCT05557708 2025-07-08

A Safety Study of 212Pb-Pentixather Radioligand Therapy

20 enrolled

Small Cell Lung Carcinoma

NCT07015892 2025-06-11

ESCALADOR

300 enrolled

Small Cell Lung Carcinoma

NCT07004712 2025-06-08

Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer

46 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Small Cell Lung Carcinoma

NCT07007325 2025-06-05

PASSIFLORE

15 enrolled

Small Cell Lung Carcinoma

NCT06961201 2025-05-07

Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia Phase

94 enrolled

Phase 4 Not yet recruiting

Small Cell Lung Carcinoma

NCT06951841 2025-04-30

Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction

31 enrolled

Small Cell Lung Carcinoma

NCT06914050 2025-04-25

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Phase 4 Not yet recruiting

Small Cell Lung Carcinoma

NCT06931145 2025-04-23

Benmelstobart, Anlotinib and Chemotherapy as First-line Treatment for Extensive-stage Small-cell Lung Cancer

50 enrolled

Small Cell Lung Carcinoma

NCT06936735 2025-04-20

Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

502 enrolled

EndocrineThoracic

Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT06909383 2025-04-03

Nanocrystalline Megestrol Acetate for the Treatment of Anorexia-Cachexia Syndrome in Extensive-Stage Small Cell Lung Cancer: A Prospective, Open-Label, Single-Arm Phase II Clinical Study

41 enrolled

Small Cell Lung Carcinoma

NCT06775002 2025-03-31

SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type

223 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT06789796 2025-02-11

a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

636 enrolled